Anticoagulant protein S in COVID-19: low activity, and associated with outcome

Anticoagulant protein S in COVID-19: low activity, and associated with outcome

Introduction. COVID-19 disease was associated with both thrombo-embolic events and in-situ thrombi formation in small vessels. Antiphospholipidic antibodies were found in some studies.

Bibliographic Details
Main Authors: Stoichitoiu Laura Elena, Pinte Larisa, Balea Marius Ioan, Nedelcu Valentin, Badea Camelia, Baicus Cristian
Format: Article
Language:English
Published: Sciendo 2020-12-01
Series:Romanian Journal of Internal Medicine
Subjects:
covid-19
protein s
thrombophilia
thrombosis
neutrophilia
Online Access:https://doi.org/10.2478/rjim-2020-0024

Similar Items

Similar Items